Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High Risk Patients with Heart Failure

BACKGROUND: Heart failure (HF) guidelines recommend routine monitoring of serum potassium and renal function in patients treated with a mineralocorticoid receptor antagonist (MRA). How these recommendations are implemented in high risk patients or according to setting of drug initiation is poorly ch...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Circ Cardiovasc Qual Outcomes
Päätekijät: Cooper, Lauren B., Hammill, Bradley G., Peterson, Eric D., Pitt, Bertram, Maciejewski, Matthew L., Curtis, Lesley H., Hernandez, Adrian F.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5228387/
https://ncbi.nlm.nih.gov/pubmed/28073850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.116.002946
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia